business backgrounder | industry
Recognizing the untapped potential in contract
pharmaceutical manufacturing, Bonanzino invested
everything he had and, with backing from the investment
firm Windward Capital Partners, purchased the company.
“That contract business really transformed the business,”
Bonanzino said.
By 2007, Windward was looking to make a return on its
investment and found a buyer in Jubilant.
Now, Jubilant HollisterStier consists of two separate
business units: Jubilant HollisterStier Contract Manufacturing & Services and HollisterStier Allergy.
The contract manufacturing unit accounts for the majority
of revenue and virtually all of the company’s growth.
Jubilant HollisterStier:
www.jublhs.com
HollisterStier Allergy:
www.hsallergy.com
no margin of error
Since the acquisition, Jubilant has continued to grow
the contract pharmaceutical business, raising its profile
within the industry and earning AWB’s Manufacturer of
the Year award in 2010.
But even if you’re a consumer of Jubilant HollisterStier’s products, chances are you’re not familiar with its
name or logo. The name on the syringe that ends up in a
doctor’s office generally belongs to Jubilant’s customer.
Jubilant doesn’t identify its customers by name, but
Morales said they include seven of the world’s 10 largest
pharmaceutical companies.
Examples of its products include vaccines, cancer
agents, and injectable medicine used to treat Alzheimer’s
and cardiovascular disease.
To make allergy extracts, the company routinely collects
The level of scrutiny over
dust samples, tree blossoms, bees and other materials in order
manufacturers of injectable
to obtain extracts. In the 1960s and ‘70s, Girl Scouts and other
pharmaceuticals is considernonprofits held “dust drives.” Going door to door collecting dust
able — and for good reason.
from vacuum cleaners paid about 50 cents per pound.
If s o m e o n e t a ke s a n o ra l
m e d i c i n e t h a t ’s c o n t a m i nated, the body has a natural
defense mechanism: It can
reject it. But when you inject
a medicine directly into the
b l o o d s t re a m , t h e b o d y i s
defenseless.
T h a t m e a n s e ve r y d a y
at the company ’s Spokane
manufacturing facility is
treated as if it’s inspection
day. The workflow is similar
to any modern manufacturing
facility, Morales said, except
with hypersensitivity toward
temperature control and
keeping the product sterile.
Empty vials go into a
restricted status the moment
they arrive and care is
taken to prevent any contamination at every stop in the
process. It takes six months of
40 association of washington business